Evidence map›Paper›PMID 34374814›Full record

ArticleExperimental brain research2021

Measurement error and reliability of TMS metrics collected from biceps and triceps in individuals with chronic incomplete tetraplegia.

Tarun Arora, Kelsey Potter-Baker, Kyle O'Laughlin, Manshi Li, Xiaofeng Wang, David Cunningham, Francois Bethoux, Frederick Frost, Ela B Plow

Abstract read
PubMed Publisher
In one paragraph

Article in Experimental brain research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tarun AroraPlow Lab (ND 20), Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, ND20, Cleveland, OH, 44195, USA.
Kelsey Potter-BakerDepartment of Molecular Science, School of Medicine, The University of Texas Rio Grande Valley, Edinburg, TX, USA.
Kyle O'LaughlinPlow Lab (ND 20), Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, ND20, Cleveland, OH, 44195, USA.
Manshi LiDepartment of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA.
Xiaofeng WangDepartment of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA.
David CunninghamMetroHealth Center for Rehabilitation Research, Cleveland, OH, USA.
Francois BethouxDepartment of Physical Medicine and Rehabilitation, Cleveland Clinic Foundation, Cleveland, USA.
Frederick FrostDepartment of Physical Medicine and Rehabilitation, Cleveland Clinic Foundation, Cleveland, USA.
Ela B PlowPlow Lab (ND 20), Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, ND20, Cleveland, OH, 44195, USA. plowe2@ccf.org.
Cleveland Clinic · USCase Western Reserve University · USThe University of Texas Rio Grande Valley · US

Funding

Cleveland Clinic Research Programs Committee Award 2016-195Conquer Paralysis Now CPN1512U.S. Department of Defense W81XWH1110707U.S. Department of Defense W81XWH1810530
6 · The paper itself

Abstract

Transcranial magnetic stimulation (TMS) is used to investigate corticomotor neurophysiology associated with functional recovery in individuals with spinal cord injury (SCI). There is insufficient evidence about test-retest measurement properties of TMS in SCI. Therefore, we investigated test-retest agreement and reliability of TMS metrics representing corticomotor excitability, output, gain, map (representation), and inhibition in individuals with cervical SCI. We collected TMS metrics from biceps and triceps muscles because of the relevance of this proximal muscle pair to the cervical SCI population. Twelve individuals with chronic C3-C6 SCI participated in two TMS sessions separated by ≥ 2 weeks. Measurement agreement was evaluated using t tests, Bland-Altman limits of agreement and relative standard error of measurement (SEM%), while reliability was investigated using intra-class correlation coefficient (ICC) and concordance correlation coefficient (CCC). We calculated the smallest detectable change for all TMS metrics. All TMS metrics except antero-posterior map coordinates and corticomotor inhibition were in agreement upon repeated measurement though limits of agreement were generally large. Measures of corticomotor excitability, output and medio-lateral map coordinates had superior agreement (SEM% < 10). Metrics representing corticomotor excitability, output, and inhibition had good-to-excellent reliability (ICC/CCC > 0.75). The smallest detectable change for TMS metrics was generally high for a single individual, but this value reduced substantially with increase in sample size. We recommend use of corticomotor excitability and recruitment curve area owing to their superior measurement properties. A modest group size (20 or above) yields more stable measurements, which may favor use of TMS metrics in group level modulation after SCI.

Indexed as

Transcranial Magnetic StimulationEvoked Potentials, MotorHumansQuadriplegiaReproducibility of ResultsMeasurement errorReliabilitySmallest detectable changeSpinal cord injuryTranscranial magnetic stimulation

Identifiers

PMID34374814
OpenAlexW3191604171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.